Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Celadon Pharmaceuticals (CEL)

Sector:

Alternative Investment Instruments

Index:

FTSE AIM All-Share

115.00p

Change Today:

-2.50p
52 Week High: 172.50
52 Week Low: 79.00

Currency: UK Pounds
Shares Issued: 64.21m
Volume: 110,673

Market Cap: £73.84m
RiskGrade: 111

Trade now with Barclays Stockbrokers

Update - Celadon Pharmaceuticals is a top faller in its sector - can you take advantage with spread betting? Find out more

News Channel

Celadon's new finance chief to join later in January

By Josh White

Date: Friday 13 Jan 2023

LONDON (ShareCast) - (Sharecast News) - Celadon Pharmaceuticals updated the market on the arrival of its new finance chief on Friday.
The AIM-traded cannabis-based medicines developer had announced the appointment of Jonathan Turner as its new chief financial officer on 1 November.

"[We are] pleased to announce that Jonathan Turner will formally join the company and be appointed to the board as chief financial officer on 17 January," it said in its short statement on Thursday.

At 1537 GMT, shares in Celadon Pharmaceuticals were down 0.99% at 50.99p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

CEL Market Data

Currency	UK Pounds
Share Price	115.00p
Change Today	-2.50p
% Change	-2.13 %
52 Week High	172.50
52 Week Low	79.00
Volume	110,673
Shares Issued	64.21m
Market Cap	£73.84m
RiskGrade	111